NEWS RELEASE 17-MAY-2024 Study finds the supplement effective in inhibiting fibrosis and suppressing disease activity and progression of systemic sclerosis, an intractable disease Peer-Reviewed PublicationLOUIS PASTEUR CENTER FOR MEDICAL RESEARCH OXIDATIVE STRESS IS KNOWN TO EXACERBATE FIBROSIS AND AUTOIMMUNITY. IN A NEW STUDY, RESEARCHERS FROM JAPAN HAVE INVESTIGATED THE EFFECTS OF A DIETARY ANTIOXIDANT SUPPLEMENT...
by Valerie Goodwin, University of Michigan Credit: Jacob Dwyer, Justine Ross / Michigan MedicineSystemic sclerosis causes the skin to tighten and harden resulting in a potentially fatal autoimmune condition that is associated with lung fibrosis and kidney disease. University of Michigan Health researchers have studied the pathology of systemic sclerosis to understand better the disease and...
by American College of Rheumatology Credit: Pixabay/CC0 Public Domain New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, reports the incidence and risk factors for new-onset interstitial lung disease (ILD) in previously ILD-negative systemic sclerosis patients. Interstitial lung disease is a common complication and cause of death in systemic sclerosis (SSc,...
by European Alliance of Associations for Rheumatology, EULAR Credit: Unsplash/CC0 Public Domain Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. Systemic sclerosis (SSc) or scleroderma is another rheumatic autoimmune disease that affects blood vessels, skin, and visceral organs. EULAR has previously published recommendations for the management of these two conditions...
